By Sophie Sassard, Olivia Oran and Soyoung Kim LONDON/NEW YORK (Reuters) - Sanofi SA is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion, according to people familiar with the matter, yet another example of drugmakers trying to shed non-core assets and focus on high-growth areas. The French pharmaceutical company is working with Evercore Partners Inc and has contacted potential buyers in the past few months, the people said on Tuesday, asking not to be named because the matter is private. Generic drugmakers and specialty pharmaceutical companies are seen as logical buyers for the Sanofi drug portfolio, said the people familiar with the matter. Sanofi could not be immediately reached for comment, while Evercore declined to comment.
via Health News Headlines - Yahoo News http://ift.tt/1keBKBl
No comments:
Post a Comment